nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP1B1—melanoma	0.259	0.777	CbGaD
Lansoprazole—MAPT—Docetaxel—melanoma	0.204	0.429	CbGbCtD
Lansoprazole—ABCB1—melanoma	0.0742	0.223	CbGaD
Lansoprazole—ABCG2—Vemurafenib—melanoma	0.0448	0.0941	CbGbCtD
Lansoprazole—CYP1B1—Docetaxel—melanoma	0.0324	0.0679	CbGbCtD
Lansoprazole—CYP1A1—Dacarbazine—melanoma	0.0317	0.0666	CbGbCtD
Lansoprazole—ABCG2—Dactinomycin—melanoma	0.0298	0.0625	CbGbCtD
Lansoprazole—CYP1A2—Carmustine—melanoma	0.0234	0.0491	CbGbCtD
Lansoprazole—CYP1A2—Vemurafenib—melanoma	0.0185	0.0388	CbGbCtD
Lansoprazole—CYP3A4—Temozolomide—melanoma	0.0177	0.0371	CbGbCtD
Lansoprazole—ABCG2—Docetaxel—melanoma	0.0154	0.0323	CbGbCtD
Lansoprazole—CYP2D6—Vemurafenib—melanoma	0.0152	0.032	CbGbCtD
Lansoprazole—CYP1A2—Dacarbazine—melanoma	0.0142	0.0297	CbGbCtD
Lansoprazole—ABCB1—Dactinomycin—melanoma	0.0107	0.0226	CbGbCtD
Lansoprazole—CYP3A4—Vemurafenib—melanoma	0.00968	0.0203	CbGbCtD
Lansoprazole—ABCB1—Docetaxel—melanoma	0.00555	0.0116	CbGbCtD
Lansoprazole—CYP3A4—Docetaxel—melanoma	0.00332	0.00698	CbGbCtD
Lansoprazole—Omeprazole—CYP1B1—melanoma	0.000688	0.61	CrCbGaD
Lansoprazole—Pantoprazole—ABCB1—melanoma	0.000242	0.215	CrCbGaD
Lansoprazole—Omeprazole—ABCB1—melanoma	0.000197	0.175	CrCbGaD
Lansoprazole—Alopecia—Temozolomide—melanoma	0.000127	0.00109	CcSEcCtD
Lansoprazole—Dry skin—Docetaxel—melanoma	0.000127	0.00109	CcSEcCtD
Lansoprazole—Myalgia—Bleomycin—melanoma	0.000126	0.00109	CcSEcCtD
Lansoprazole—Chest pain—Bleomycin—melanoma	0.000126	0.00109	CcSEcCtD
Lansoprazole—Rash—Vemurafenib—melanoma	0.000126	0.00108	CcSEcCtD
Lansoprazole—Mental disorder—Temozolomide—melanoma	0.000126	0.00108	CcSEcCtD
Lansoprazole—Dermatitis—Vemurafenib—melanoma	0.000126	0.00108	CcSEcCtD
Lansoprazole—Back pain—Carmustine—melanoma	0.000125	0.00108	CcSEcCtD
Lansoprazole—Headache—Vemurafenib—melanoma	0.000125	0.00108	CcSEcCtD
Lansoprazole—Malnutrition—Temozolomide—melanoma	0.000125	0.00108	CcSEcCtD
Lansoprazole—Erythema—Temozolomide—melanoma	0.000125	0.00108	CcSEcCtD
Lansoprazole—Breast disorder—Docetaxel—melanoma	0.000125	0.00107	CcSEcCtD
Lansoprazole—Discomfort—Bleomycin—melanoma	0.000125	0.00107	CcSEcCtD
Lansoprazole—Malaise—Dactinomycin—melanoma	0.000125	0.00107	CcSEcCtD
Lansoprazole—Cramp muscle—Docetaxel—melanoma	0.000125	0.00107	CcSEcCtD
Lansoprazole—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000125	0.00107	CcSEcCtD
Lansoprazole—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000125	0.00107	CcSEcCtD
Lansoprazole—Leukopenia—Dactinomycin—melanoma	0.000124	0.00106	CcSEcCtD
Lansoprazole—Nasopharyngitis—Docetaxel—melanoma	0.000124	0.00106	CcSEcCtD
Lansoprazole—Dysgeusia—Temozolomide—melanoma	0.000123	0.00105	CcSEcCtD
Lansoprazole—Confusional state—Bleomycin—melanoma	0.000122	0.00105	CcSEcCtD
Lansoprazole—Vision blurred—Carmustine—melanoma	0.000122	0.00105	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Docetaxel—melanoma	0.000122	0.00105	CcSEcCtD
Lansoprazole—Tremor—Carmustine—melanoma	0.000121	0.00104	CcSEcCtD
Lansoprazole—Anaphylactic shock—Bleomycin—melanoma	0.000121	0.00104	CcSEcCtD
Lansoprazole—Oedema—Bleomycin—melanoma	0.000121	0.00104	CcSEcCtD
Lansoprazole—Back pain—Temozolomide—melanoma	0.000121	0.00104	CcSEcCtD
Lansoprazole—Infection—Bleomycin—melanoma	0.00012	0.00103	CcSEcCtD
Lansoprazole—Anaemia—Carmustine—melanoma	0.00012	0.00103	CcSEcCtD
Lansoprazole—Dysphagia—Docetaxel—melanoma	0.00012	0.00103	CcSEcCtD
Lansoprazole—Agitation—Carmustine—melanoma	0.000119	0.00102	CcSEcCtD
Lansoprazole—Nausea—Vemurafenib—melanoma	0.000119	0.00102	CcSEcCtD
Lansoprazole—Thrombocytopenia—Bleomycin—melanoma	0.000119	0.00102	CcSEcCtD
Lansoprazole—Vision blurred—Temozolomide—melanoma	0.000118	0.00101	CcSEcCtD
Lansoprazole—Myalgia—Dactinomycin—melanoma	0.000118	0.00101	CcSEcCtD
Lansoprazole—Tremor—Temozolomide—melanoma	0.000117	0.00101	CcSEcCtD
Lansoprazole—Discomfort—Dactinomycin—melanoma	0.000116	0.001	CcSEcCtD
Lansoprazole—Angina pectoris—Docetaxel—melanoma	0.000116	0.001	CcSEcCtD
Lansoprazole—Ill-defined disorder—Temozolomide—melanoma	0.000116	0.000998	CcSEcCtD
Lansoprazole—Leukopenia—Carmustine—melanoma	0.000116	0.000996	CcSEcCtD
Lansoprazole—Anaemia—Temozolomide—melanoma	0.000116	0.000994	CcSEcCtD
Lansoprazole—Anorexia—Bleomycin—melanoma	0.000116	0.000992	CcSEcCtD
Lansoprazole—Agitation—Temozolomide—melanoma	0.000115	0.000988	CcSEcCtD
Lansoprazole—Angioedema—Temozolomide—melanoma	0.000114	0.000983	CcSEcCtD
Lansoprazole—Pancytopenia—Docetaxel—melanoma	0.000114	0.000975	CcSEcCtD
Lansoprazole—Hypotension—Bleomycin—melanoma	0.000113	0.000972	CcSEcCtD
Lansoprazole—Oedema—Dactinomycin—melanoma	0.000113	0.00097	CcSEcCtD
Lansoprazole—Malaise—Temozolomide—melanoma	0.000113	0.00097	CcSEcCtD
Lansoprazole—Vertigo—Temozolomide—melanoma	0.000113	0.000966	CcSEcCtD
Lansoprazole—Convulsion—Carmustine—melanoma	0.000112	0.000964	CcSEcCtD
Lansoprazole—Infection—Dactinomycin—melanoma	0.000112	0.000964	CcSEcCtD
Lansoprazole—Leukopenia—Temozolomide—melanoma	0.000112	0.000963	CcSEcCtD
Lansoprazole—Hypertension—Carmustine—melanoma	0.000112	0.000961	CcSEcCtD
Lansoprazole—Neutropenia—Docetaxel—melanoma	0.000112	0.00096	CcSEcCtD
Lansoprazole—Palpitations—Temozolomide—melanoma	0.000111	0.00095	CcSEcCtD
Lansoprazole—Thrombocytopenia—Dactinomycin—melanoma	0.000111	0.00095	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Bleomycin—melanoma	0.00011	0.000948	CcSEcCtD
Lansoprazole—Myalgia—Carmustine—melanoma	0.00011	0.000948	CcSEcCtD
Lansoprazole—Chest pain—Carmustine—melanoma	0.00011	0.000948	CcSEcCtD
Lansoprazole—Anxiety—Carmustine—melanoma	0.00011	0.000944	CcSEcCtD
Lansoprazole—Cough—Temozolomide—melanoma	0.000109	0.000939	CcSEcCtD
Lansoprazole—Paraesthesia—Bleomycin—melanoma	0.000109	0.000934	CcSEcCtD
Lansoprazole—Weight increased—Docetaxel—melanoma	0.000109	0.000934	CcSEcCtD
Lansoprazole—Convulsion—Temozolomide—melanoma	0.000109	0.000932	CcSEcCtD
Lansoprazole—Hypertension—Temozolomide—melanoma	0.000108	0.000929	CcSEcCtD
Lansoprazole—Dyspnoea—Bleomycin—melanoma	0.000108	0.000928	CcSEcCtD
Lansoprazole—Anorexia—Dactinomycin—melanoma	0.000108	0.000925	CcSEcCtD
Lansoprazole—Pneumonia—Docetaxel—melanoma	0.000107	0.000921	CcSEcCtD
Lansoprazole—Confusional state—Carmustine—melanoma	0.000107	0.000916	CcSEcCtD
Lansoprazole—Arthralgia—Temozolomide—melanoma	0.000107	0.000916	CcSEcCtD
Lansoprazole—Myalgia—Temozolomide—melanoma	0.000107	0.000916	CcSEcCtD
Lansoprazole—Infestation—Docetaxel—melanoma	0.000107	0.000915	CcSEcCtD
Lansoprazole—Infestation NOS—Docetaxel—melanoma	0.000107	0.000915	CcSEcCtD
Lansoprazole—Anxiety—Temozolomide—melanoma	0.000106	0.000912	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000106	0.000909	CcSEcCtD
Lansoprazole—Oedema—Carmustine—melanoma	0.000106	0.000908	CcSEcCtD
Lansoprazole—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000106	0.000907	CcSEcCtD
Lansoprazole—Discomfort—Temozolomide—melanoma	0.000105	0.000905	CcSEcCtD
Lansoprazole—Decreased appetite—Bleomycin—melanoma	0.000105	0.000905	CcSEcCtD
Lansoprazole—Infection—Carmustine—melanoma	0.000105	0.000902	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Docetaxel—melanoma	0.000105	0.000902	CcSEcCtD
Lansoprazole—Renal failure—Docetaxel—melanoma	0.000105	0.0009	CcSEcCtD
Lansoprazole—Myocardial infarction—Docetaxel—melanoma	0.000104	0.000897	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Docetaxel—melanoma	0.000104	0.000897	CcSEcCtD
Lansoprazole—Dry mouth—Temozolomide—melanoma	0.000104	0.000896	CcSEcCtD
Lansoprazole—Stomatitis—Docetaxel—melanoma	0.000104	0.000892	CcSEcCtD
Lansoprazole—Jaundice—Docetaxel—melanoma	0.000104	0.000892	CcSEcCtD
Lansoprazole—Pain—Bleomycin—melanoma	0.000104	0.00089	CcSEcCtD
Lansoprazole—Conjunctivitis—Docetaxel—melanoma	0.000104	0.00089	CcSEcCtD
Lansoprazole—Thrombocytopenia—Carmustine—melanoma	0.000104	0.000889	CcSEcCtD
Lansoprazole—Tachycardia—Carmustine—melanoma	0.000103	0.000887	CcSEcCtD
Lansoprazole—Confusional state—Temozolomide—melanoma	0.000103	0.000885	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000103	0.000884	CcSEcCtD
Lansoprazole—Anaphylactic shock—Temozolomide—melanoma	0.000102	0.000878	CcSEcCtD
Lansoprazole—Oedema—Temozolomide—melanoma	0.000102	0.000878	CcSEcCtD
Lansoprazole—Infection—Temozolomide—melanoma	0.000102	0.000872	CcSEcCtD
Lansoprazole—Anorexia—Carmustine—melanoma	0.000101	0.000866	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Docetaxel—melanoma	0.000101	0.000866	CcSEcCtD
Lansoprazole—Epistaxis—Docetaxel—melanoma	0.000101	0.000863	CcSEcCtD
Lansoprazole—Nervous system disorder—Temozolomide—melanoma	0.0001	0.000861	CcSEcCtD
Lansoprazole—Thrombocytopenia—Temozolomide—melanoma	0.0001	0.000859	CcSEcCtD
Lansoprazole—Feeling abnormal—Bleomycin—melanoma	9.99e-05	0.000858	CcSEcCtD
Lansoprazole—Agranulocytosis—Docetaxel—melanoma	9.95e-05	0.000854	CcSEcCtD
Lansoprazole—Skin disorder—Temozolomide—melanoma	9.93e-05	0.000853	CcSEcCtD
Lansoprazole—Hypotension—Carmustine—melanoma	9.89e-05	0.000849	CcSEcCtD
Lansoprazole—Hyperhidrosis—Temozolomide—melanoma	9.88e-05	0.000849	CcSEcCtD
Lansoprazole—Decreased appetite—Dactinomycin—melanoma	9.83e-05	0.000844	CcSEcCtD
Lansoprazole—Fatigue—Dactinomycin—melanoma	9.74e-05	0.000837	CcSEcCtD
Lansoprazole—Anorexia—Temozolomide—melanoma	9.74e-05	0.000837	CcSEcCtD
Lansoprazole—Pain—Dactinomycin—melanoma	9.67e-05	0.00083	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Carmustine—melanoma	9.64e-05	0.000828	CcSEcCtD
Lansoprazole—Urticaria—Bleomycin—melanoma	9.63e-05	0.000827	CcSEcCtD
Lansoprazole—Rhinitis—Docetaxel—melanoma	9.59e-05	0.000824	CcSEcCtD
Lansoprazole—Body temperature increased—Bleomycin—melanoma	9.58e-05	0.000823	CcSEcCtD
Lansoprazole—Hepatitis—Docetaxel—melanoma	9.57e-05	0.000822	CcSEcCtD
Lansoprazole—Insomnia—Carmustine—melanoma	9.57e-05	0.000822	CcSEcCtD
Lansoprazole—Hypoaesthesia—Docetaxel—melanoma	9.52e-05	0.000818	CcSEcCtD
Lansoprazole—Paraesthesia—Carmustine—melanoma	9.5e-05	0.000816	CcSEcCtD
Lansoprazole—Pharyngitis—Docetaxel—melanoma	9.5e-05	0.000815	CcSEcCtD
Lansoprazole—Urinary tract disorder—Docetaxel—melanoma	9.45e-05	0.000811	CcSEcCtD
Lansoprazole—Dyspnoea—Carmustine—melanoma	9.43e-05	0.00081	CcSEcCtD
Lansoprazole—Oedema peripheral—Docetaxel—melanoma	9.43e-05	0.000809	CcSEcCtD
Lansoprazole—Somnolence—Carmustine—melanoma	9.4e-05	0.000807	CcSEcCtD
Lansoprazole—Connective tissue disorder—Docetaxel—melanoma	9.4e-05	0.000807	CcSEcCtD
Lansoprazole—Urethral disorder—Docetaxel—melanoma	9.38e-05	0.000805	CcSEcCtD
Lansoprazole—Feeling abnormal—Dactinomycin—melanoma	9.31e-05	0.0008	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Temozolomide—melanoma	9.31e-05	0.0008	CcSEcCtD
Lansoprazole—Insomnia—Temozolomide—melanoma	9.25e-05	0.000794	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Dactinomycin—melanoma	9.24e-05	0.000794	CcSEcCtD
Lansoprazole—Visual impairment—Docetaxel—melanoma	9.22e-05	0.000792	CcSEcCtD
Lansoprazole—Decreased appetite—Carmustine—melanoma	9.2e-05	0.00079	CcSEcCtD
Lansoprazole—Paraesthesia—Temozolomide—melanoma	9.18e-05	0.000788	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Carmustine—melanoma	9.13e-05	0.000784	CcSEcCtD
Lansoprazole—Dyspnoea—Temozolomide—melanoma	9.11e-05	0.000783	CcSEcCtD
Lansoprazole—Somnolence—Temozolomide—melanoma	9.09e-05	0.00078	CcSEcCtD
Lansoprazole—Erythema multiforme—Docetaxel—melanoma	9.05e-05	0.000777	CcSEcCtD
Lansoprazole—Pain—Carmustine—melanoma	9.05e-05	0.000777	CcSEcCtD
Lansoprazole—Constipation—Carmustine—melanoma	9.05e-05	0.000777	CcSEcCtD
Lansoprazole—Dyspepsia—Temozolomide—melanoma	9e-05	0.000773	CcSEcCtD
Lansoprazole—Eye disorder—Docetaxel—melanoma	8.94e-05	0.000768	CcSEcCtD
Lansoprazole—Body temperature increased—Dactinomycin—melanoma	8.94e-05	0.000767	CcSEcCtD
Lansoprazole—Abdominal pain—Dactinomycin—melanoma	8.94e-05	0.000767	CcSEcCtD
Lansoprazole—Hypersensitivity—Bleomycin—melanoma	8.93e-05	0.000767	CcSEcCtD
Lansoprazole—Decreased appetite—Temozolomide—melanoma	8.89e-05	0.000763	CcSEcCtD
Lansoprazole—Cardiac disorder—Docetaxel—melanoma	8.88e-05	0.000763	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Temozolomide—melanoma	8.83e-05	0.000758	CcSEcCtD
Lansoprazole—Fatigue—Temozolomide—melanoma	8.81e-05	0.000757	CcSEcCtD
Lansoprazole—Pain—Temozolomide—melanoma	8.74e-05	0.000751	CcSEcCtD
Lansoprazole—Constipation—Temozolomide—melanoma	8.74e-05	0.000751	CcSEcCtD
Lansoprazole—Feeling abnormal—Carmustine—melanoma	8.72e-05	0.000749	CcSEcCtD
Lansoprazole—Asthenia—Bleomycin—melanoma	8.7e-05	0.000747	CcSEcCtD
Lansoprazole—Angiopathy—Docetaxel—melanoma	8.68e-05	0.000745	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Carmustine—melanoma	8.65e-05	0.000743	CcSEcCtD
Lansoprazole—Immune system disorder—Docetaxel—melanoma	8.64e-05	0.000742	CcSEcCtD
Lansoprazole—Mediastinal disorder—Docetaxel—melanoma	8.62e-05	0.00074	CcSEcCtD
Lansoprazole—Chills—Docetaxel—melanoma	8.59e-05	0.000737	CcSEcCtD
Lansoprazole—Pruritus—Bleomycin—melanoma	8.57e-05	0.000736	CcSEcCtD
Lansoprazole—Arrhythmia—Docetaxel—melanoma	8.55e-05	0.000734	CcSEcCtD
Lansoprazole—Alopecia—Docetaxel—melanoma	8.46e-05	0.000726	CcSEcCtD
Lansoprazole—Feeling abnormal—Temozolomide—melanoma	8.42e-05	0.000723	CcSEcCtD
Lansoprazole—Mental disorder—Docetaxel—melanoma	8.38e-05	0.00072	CcSEcCtD
Lansoprazole—Abdominal pain—Carmustine—melanoma	8.36e-05	0.000718	CcSEcCtD
Lansoprazole—Body temperature increased—Carmustine—melanoma	8.36e-05	0.000718	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Temozolomide—melanoma	8.36e-05	0.000718	CcSEcCtD
Lansoprazole—Malnutrition—Docetaxel—melanoma	8.33e-05	0.000715	CcSEcCtD
Lansoprazole—Erythema—Docetaxel—melanoma	8.33e-05	0.000715	CcSEcCtD
Lansoprazole—Hypersensitivity—Dactinomycin—melanoma	8.33e-05	0.000715	CcSEcCtD
Lansoprazole—Dysgeusia—Docetaxel—melanoma	8.16e-05	0.0007	CcSEcCtD
Lansoprazole—Urticaria—Temozolomide—melanoma	8.12e-05	0.000697	CcSEcCtD
Lansoprazole—Asthenia—Dactinomycin—melanoma	8.11e-05	0.000696	CcSEcCtD
Lansoprazole—Abdominal pain—Temozolomide—melanoma	8.08e-05	0.000694	CcSEcCtD
Lansoprazole—Body temperature increased—Temozolomide—melanoma	8.08e-05	0.000694	CcSEcCtD
Lansoprazole—Back pain—Docetaxel—melanoma	8.06e-05	0.000692	CcSEcCtD
Lansoprazole—Muscle spasms—Docetaxel—melanoma	8.01e-05	0.000688	CcSEcCtD
Lansoprazole—Hypersensitivity—Carmustine—melanoma	7.79e-05	0.000669	CcSEcCtD
Lansoprazole—Diarrhoea—Dactinomycin—melanoma	7.73e-05	0.000664	CcSEcCtD
Lansoprazole—Vomiting—Bleomycin—melanoma	7.71e-05	0.000662	CcSEcCtD
Lansoprazole—Anaemia—Docetaxel—melanoma	7.7e-05	0.000661	CcSEcCtD
Lansoprazole—Rash—Bleomycin—melanoma	7.64e-05	0.000656	CcSEcCtD
Lansoprazole—Dermatitis—Bleomycin—melanoma	7.63e-05	0.000656	CcSEcCtD
Lansoprazole—Asthenia—Carmustine—melanoma	7.59e-05	0.000652	CcSEcCtD
Lansoprazole—Hypersensitivity—Temozolomide—melanoma	7.53e-05	0.000647	CcSEcCtD
Lansoprazole—Syncope—Docetaxel—melanoma	7.47e-05	0.000641	CcSEcCtD
Lansoprazole—Leukopenia—Docetaxel—melanoma	7.46e-05	0.00064	CcSEcCtD
Lansoprazole—Palpitations—Docetaxel—melanoma	7.36e-05	0.000632	CcSEcCtD
Lansoprazole—Asthenia—Temozolomide—melanoma	7.33e-05	0.00063	CcSEcCtD
Lansoprazole—Loss of consciousness—Docetaxel—melanoma	7.32e-05	0.000629	CcSEcCtD
Lansoprazole—Cough—Docetaxel—melanoma	7.27e-05	0.000624	CcSEcCtD
Lansoprazole—Diarrhoea—Carmustine—melanoma	7.24e-05	0.000621	CcSEcCtD
Lansoprazole—Pruritus—Temozolomide—melanoma	7.23e-05	0.000621	CcSEcCtD
Lansoprazole—Convulsion—Docetaxel—melanoma	7.22e-05	0.00062	CcSEcCtD
Lansoprazole—Nausea—Bleomycin—melanoma	7.2e-05	0.000618	CcSEcCtD
Lansoprazole—Hypertension—Docetaxel—melanoma	7.19e-05	0.000618	CcSEcCtD
Lansoprazole—Vomiting—Dactinomycin—melanoma	7.19e-05	0.000617	CcSEcCtD
Lansoprazole—Rash—Dactinomycin—melanoma	7.13e-05	0.000612	CcSEcCtD
Lansoprazole—Chest pain—Docetaxel—melanoma	7.09e-05	0.000609	CcSEcCtD
Lansoprazole—Arthralgia—Docetaxel—melanoma	7.09e-05	0.000609	CcSEcCtD
Lansoprazole—Myalgia—Docetaxel—melanoma	7.09e-05	0.000609	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	7.04e-05	0.000605	CcSEcCtD
Lansoprazole—Dizziness—Carmustine—melanoma	7e-05	0.000601	CcSEcCtD
Lansoprazole—Diarrhoea—Temozolomide—melanoma	6.99e-05	0.000601	CcSEcCtD
Lansoprazole—Dry mouth—Docetaxel—melanoma	6.94e-05	0.000596	CcSEcCtD
Lansoprazole—Confusional state—Docetaxel—melanoma	6.86e-05	0.000589	CcSEcCtD
Lansoprazole—Oedema—Docetaxel—melanoma	6.8e-05	0.000584	CcSEcCtD
Lansoprazole—Anaphylactic shock—Docetaxel—melanoma	6.8e-05	0.000584	CcSEcCtD
Lansoprazole—Dizziness—Temozolomide—melanoma	6.76e-05	0.00058	CcSEcCtD
Lansoprazole—Infection—Docetaxel—melanoma	6.75e-05	0.00058	CcSEcCtD
Lansoprazole—Vomiting—Carmustine—melanoma	6.73e-05	0.000578	CcSEcCtD
Lansoprazole—Nausea—Dactinomycin—melanoma	6.71e-05	0.000576	CcSEcCtD
Lansoprazole—Shock—Docetaxel—melanoma	6.69e-05	0.000574	CcSEcCtD
Lansoprazole—Rash—Carmustine—melanoma	6.67e-05	0.000573	CcSEcCtD
Lansoprazole—Nervous system disorder—Docetaxel—melanoma	6.67e-05	0.000572	CcSEcCtD
Lansoprazole—Dermatitis—Carmustine—melanoma	6.66e-05	0.000572	CcSEcCtD
Lansoprazole—Thrombocytopenia—Docetaxel—melanoma	6.66e-05	0.000572	CcSEcCtD
Lansoprazole—Tachycardia—Docetaxel—melanoma	6.64e-05	0.00057	CcSEcCtD
Lansoprazole—Headache—Carmustine—melanoma	6.63e-05	0.000569	CcSEcCtD
Lansoprazole—Skin disorder—Docetaxel—melanoma	6.6e-05	0.000567	CcSEcCtD
Lansoprazole—Vomiting—Temozolomide—melanoma	6.5e-05	0.000558	CcSEcCtD
Lansoprazole—Anorexia—Docetaxel—melanoma	6.48e-05	0.000556	CcSEcCtD
Lansoprazole—Rash—Temozolomide—melanoma	6.45e-05	0.000553	CcSEcCtD
Lansoprazole—Dermatitis—Temozolomide—melanoma	6.44e-05	0.000553	CcSEcCtD
Lansoprazole—Headache—Temozolomide—melanoma	6.4e-05	0.00055	CcSEcCtD
Lansoprazole—Hypotension—Docetaxel—melanoma	6.35e-05	0.000545	CcSEcCtD
Lansoprazole—Nausea—Carmustine—melanoma	6.28e-05	0.00054	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Docetaxel—melanoma	6.19e-05	0.000532	CcSEcCtD
Lansoprazole—Insomnia—Docetaxel—melanoma	6.15e-05	0.000528	CcSEcCtD
Lansoprazole—Paraesthesia—Docetaxel—melanoma	6.1e-05	0.000524	CcSEcCtD
Lansoprazole—Nausea—Temozolomide—melanoma	6.07e-05	0.000521	CcSEcCtD
Lansoprazole—Dyspnoea—Docetaxel—melanoma	6.06e-05	0.00052	CcSEcCtD
Lansoprazole—Somnolence—Docetaxel—melanoma	6.04e-05	0.000519	CcSEcCtD
Lansoprazole—Dyspepsia—Docetaxel—melanoma	5.98e-05	0.000514	CcSEcCtD
Lansoprazole—Decreased appetite—Docetaxel—melanoma	5.91e-05	0.000507	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Docetaxel—melanoma	5.87e-05	0.000504	CcSEcCtD
Lansoprazole—Fatigue—Docetaxel—melanoma	5.86e-05	0.000503	CcSEcCtD
Lansoprazole—Constipation—Docetaxel—melanoma	5.81e-05	0.000499	CcSEcCtD
Lansoprazole—Pain—Docetaxel—melanoma	5.81e-05	0.000499	CcSEcCtD
Lansoprazole—Feeling abnormal—Docetaxel—melanoma	5.6e-05	0.000481	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Docetaxel—melanoma	5.56e-05	0.000477	CcSEcCtD
Lansoprazole—Abdominal pain—Docetaxel—melanoma	5.37e-05	0.000461	CcSEcCtD
Lansoprazole—Body temperature increased—Docetaxel—melanoma	5.37e-05	0.000461	CcSEcCtD
Lansoprazole—Hypersensitivity—Docetaxel—melanoma	5.01e-05	0.00043	CcSEcCtD
Lansoprazole—Asthenia—Docetaxel—melanoma	4.88e-05	0.000419	CcSEcCtD
Lansoprazole—Pruritus—Docetaxel—melanoma	4.81e-05	0.000413	CcSEcCtD
Lansoprazole—Diarrhoea—Docetaxel—melanoma	4.65e-05	0.000399	CcSEcCtD
Lansoprazole—Dizziness—Docetaxel—melanoma	4.5e-05	0.000386	CcSEcCtD
Lansoprazole—Vomiting—Docetaxel—melanoma	4.32e-05	0.000371	CcSEcCtD
Lansoprazole—Rash—Docetaxel—melanoma	4.29e-05	0.000368	CcSEcCtD
Lansoprazole—Dermatitis—Docetaxel—melanoma	4.28e-05	0.000368	CcSEcCtD
Lansoprazole—Headache—Docetaxel—melanoma	4.26e-05	0.000366	CcSEcCtD
Lansoprazole—Nausea—Docetaxel—melanoma	4.04e-05	0.000347	CcSEcCtD
Lansoprazole—CYP1A2—Metabolism—SDHD—melanoma	5.76e-06	7.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—BSG—melanoma	5.76e-06	7.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CSPG4—melanoma	5.76e-06	7.88e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	5.65e-06	7.73e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP17A1—melanoma	5.64e-06	7.71e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PLA2G6—melanoma	5.6e-06	7.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.6e-06	7.65e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPAM—melanoma	5.58e-06	7.63e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.56e-06	7.6e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PLA2G6—melanoma	5.55e-06	7.59e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC6A11—melanoma	5.52e-06	7.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIP4K2A—melanoma	5.52e-06	7.54e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—melanoma	5.49e-06	7.51e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—VCAN—melanoma	5.47e-06	7.48e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	5.47e-06	7.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CD—melanoma	5.46e-06	7.46e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CB—melanoma	5.44e-06	7.44e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—melanoma	5.39e-06	7.37e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ALB—melanoma	5.39e-06	7.36e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTAP—melanoma	5.37e-06	7.34e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—VCAN—melanoma	5.34e-06	7.3e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GNA11—melanoma	5.33e-06	7.28e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PRKCA—melanoma	5.31e-06	7.27e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ERCC2—melanoma	5.27e-06	7.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—FASN—melanoma	5.21e-06	7.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.18e-06	7.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP17A1—melanoma	5.17e-06	7.07e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—SLC5A5—melanoma	5.13e-06	7.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.1e-06	6.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	5.03e-06	6.88e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—VCAN—melanoma	5.03e-06	6.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	5e-06	6.83e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—VCAN—melanoma	4.99e-06	6.82e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CD44—melanoma	4.95e-06	6.77e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GNAQ—melanoma	4.95e-06	6.77e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GNA11—melanoma	4.88e-06	6.68e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.85e-06	6.63e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.8e-06	6.57e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.8e-06	6.56e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PHGDH—melanoma	4.78e-06	6.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LUM—melanoma	4.78e-06	6.54e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—FASN—melanoma	4.78e-06	6.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CB—melanoma	4.76e-06	6.5e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP1B1—melanoma	4.75e-06	6.49e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PLA2G6—melanoma	4.74e-06	6.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.72e-06	6.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—melanoma	4.71e-06	6.44e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTEN—melanoma	4.7e-06	6.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—SLC5A5—melanoma	4.7e-06	6.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HPSE—melanoma	4.69e-06	6.41e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	4.62e-06	6.31e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP17A1—melanoma	4.61e-06	6.31e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CUBN—melanoma	4.6e-06	6.29e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CG—melanoma	4.58e-06	6.26e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.56e-06	6.23e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.55e-06	6.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GNAQ—melanoma	4.54e-06	6.21e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CD44—melanoma	4.54e-06	6.21e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP17A1—melanoma	4.5e-06	6.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	4.49e-06	6.14e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SDHD—melanoma	4.45e-06	6.08e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CSPG4—melanoma	4.45e-06	6.08e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—BSG—melanoma	4.45e-06	6.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.44e-06	6.08e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PPARG—melanoma	4.42e-06	6.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.4e-06	6.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GNA11—melanoma	4.36e-06	5.96e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP1B1—melanoma	4.35e-06	5.95e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPAM—melanoma	4.31e-06	5.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—FASN—melanoma	4.26e-06	5.83e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—VCAN—melanoma	4.26e-06	5.83e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GNA11—melanoma	4.25e-06	5.82e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP17A1—melanoma	4.24e-06	5.8e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP17A1—melanoma	4.21e-06	5.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—SLC5A5—melanoma	4.19e-06	5.74e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.19e-06	5.73e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	4.17e-06	5.7e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CG—melanoma	4.16e-06	5.69e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—FASN—melanoma	4.16e-06	5.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.15e-06	5.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTEN—melanoma	4.11e-06	5.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	4.1e-06	5.6e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—SLC5A5—melanoma	4.09e-06	5.6e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GNAQ—melanoma	4.05e-06	5.54e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CD44—melanoma	4.05e-06	5.54e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.03e-06	5.52e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CD—melanoma	4.02e-06	5.5e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARG—melanoma	4.02e-06	5.49e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GNA11—melanoma	4.01e-06	5.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GNA11—melanoma	3.97e-06	5.43e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—melanoma	3.97e-06	5.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.97e-06	5.42e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CD44—melanoma	3.95e-06	5.41e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GNAQ—melanoma	3.95e-06	5.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.93e-06	5.37e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—FASN—melanoma	3.92e-06	5.36e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCB1—melanoma	3.91e-06	5.34e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.89e-06	5.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—FASN—melanoma	3.89e-06	5.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP1B1—melanoma	3.88e-06	5.31e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC5A5—melanoma	3.86e-06	5.28e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.84e-06	5.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC5A5—melanoma	3.82e-06	5.23e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP1B1—melanoma	3.79e-06	5.18e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GNAQ—melanoma	3.73e-06	5.09e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CD44—melanoma	3.73e-06	5.09e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GNAQ—melanoma	3.69e-06	5.05e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CD44—melanoma	3.69e-06	5.05e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLA2G6—melanoma	3.66e-06	5.01e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CD—melanoma	3.66e-06	5e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.62e-06	4.95e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—melanoma	3.61e-06	4.94e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PRKCA—melanoma	3.6e-06	4.92e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP17A1—melanoma	3.6e-06	4.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.58e-06	4.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCB1—melanoma	3.58e-06	4.9e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP1B1—melanoma	3.57e-06	4.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ERCC2—melanoma	3.57e-06	4.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.55e-06	4.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP1B1—melanoma	3.54e-06	4.84e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CB—melanoma	3.51e-06	4.79e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.5e-06	4.79e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—melanoma	3.47e-06	4.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.43e-06	4.69e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GNA11—melanoma	3.4e-06	4.64e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—FASN—melanoma	3.32e-06	4.54e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PIK3CA—melanoma	3.32e-06	4.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PRKCA—melanoma	3.3e-06	4.51e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—VCAN—melanoma	3.29e-06	4.5e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ERCC2—melanoma	3.27e-06	4.47e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC5A5—melanoma	3.27e-06	4.47e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCB1—melanoma	3.2e-06	4.37e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CB—melanoma	3.19e-06	4.36e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—melanoma	3.16e-06	4.32e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CD44—melanoma	3.16e-06	4.32e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GNAQ—melanoma	3.16e-06	4.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.13e-06	4.27e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.09e-06	4.23e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.06e-06	4.19e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTEN—melanoma	3.03e-06	4.14e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP1B1—melanoma	3.03e-06	4.14e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.96e-06	4.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PRKCA—melanoma	2.94e-06	4.02e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCB1—melanoma	2.94e-06	4.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ERCC2—melanoma	2.92e-06	3.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCB1—melanoma	2.92e-06	3.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PIK3CA—melanoma	2.9e-06	3.96e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PRKCA—melanoma	2.87e-06	3.93e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ERCC2—melanoma	2.85e-06	3.9e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CG—melanoma	2.82e-06	3.85e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP17A1—melanoma	2.77e-06	3.79e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTEN—melanoma	2.76e-06	3.77e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—melanoma	2.72e-06	3.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.71e-06	3.7e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—melanoma	2.71e-06	3.7e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PRKCA—melanoma	2.71e-06	3.7e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ERCC2—melanoma	2.69e-06	3.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PRKCA—melanoma	2.68e-06	3.67e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.67e-06	3.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ERCC2—melanoma	2.66e-06	3.64e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GNA11—melanoma	2.62e-06	3.58e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CG—melanoma	2.58e-06	3.53e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—FASN—melanoma	2.56e-06	3.51e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC5A5—melanoma	2.52e-06	3.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—melanoma	2.49e-06	3.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCB1—melanoma	2.49e-06	3.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CD—melanoma	2.48e-06	3.39e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—melanoma	2.45e-06	3.34e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GNAQ—melanoma	2.44e-06	3.33e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CD44—melanoma	2.44e-06	3.33e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.42e-06	3.31e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—melanoma	2.37e-06	3.24e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP1B1—melanoma	2.34e-06	3.19e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CG—melanoma	2.31e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PRKCA—melanoma	2.29e-06	3.14e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ERCC2—melanoma	2.27e-06	3.11e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CD—melanoma	2.27e-06	3.1e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CG—melanoma	2.25e-06	3.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—melanoma	2.24e-06	3.06e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—melanoma	2.23e-06	3.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.21e-06	3.01e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—melanoma	2.17e-06	2.97e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CB—melanoma	2.16e-06	2.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—melanoma	2.14e-06	2.92e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PIK3CA—melanoma	2.14e-06	2.92e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CG—melanoma	2.12e-06	2.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CG—melanoma	2.1e-06	2.87e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—melanoma	2.05e-06	2.8e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—melanoma	2.03e-06	2.77e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CD—melanoma	2.03e-06	2.77e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—melanoma	2e-06	2.74e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CB—melanoma	1.98e-06	2.71e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CD—melanoma	1.98e-06	2.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—melanoma	1.96e-06	2.68e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—melanoma	1.95e-06	2.67e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3CA—melanoma	1.94e-06	2.66e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCB1—melanoma	1.92e-06	2.63e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.88e-06	2.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTEN—melanoma	1.87e-06	2.55e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CD—melanoma	1.86e-06	2.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CD—melanoma	1.85e-06	2.53e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—melanoma	1.84e-06	2.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—melanoma	1.82e-06	2.49e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CG—melanoma	1.8e-06	2.46e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PRKCA—melanoma	1.77e-06	2.42e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CB—melanoma	1.77e-06	2.42e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ERCC2—melanoma	1.76e-06	2.4e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—melanoma	1.75e-06	2.39e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—melanoma	1.75e-06	2.39e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—melanoma	1.73e-06	2.37e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CB—melanoma	1.72e-06	2.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTEN—melanoma	1.71e-06	2.34e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—melanoma	1.71e-06	2.34e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CB—melanoma	1.62e-06	2.22e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CB—melanoma	1.61e-06	2.2e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—melanoma	1.61e-06	2.2e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—melanoma	1.6e-06	2.18e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—melanoma	1.59e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CD—melanoma	1.58e-06	2.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—melanoma	1.56e-06	2.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTEN—melanoma	1.53e-06	2.09e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTEN—melanoma	1.49e-06	2.04e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTEN—melanoma	1.4e-06	1.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTEN—melanoma	1.39e-06	1.9e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CG—melanoma	1.39e-06	1.9e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CB—melanoma	1.38e-06	1.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—melanoma	1.36e-06	1.86e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—melanoma	1.34e-06	1.83e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3CA—melanoma	1.32e-06	1.8e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CD—melanoma	1.22e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3CA—melanoma	1.21e-06	1.65e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—melanoma	1.2e-06	1.65e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTEN—melanoma	1.19e-06	1.63e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3CA—melanoma	1.08e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—melanoma	1.08e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CB—melanoma	1.06e-06	1.45e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—melanoma	1.05e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3CA—melanoma	1.05e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3CA—melanoma	9.91e-07	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—melanoma	9.86e-07	1.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3CA—melanoma	9.82e-07	1.34e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTEN—melanoma	9.18e-07	1.26e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—melanoma	8.8e-07	1.2e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—melanoma	8.59e-07	1.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3CA—melanoma	8.39e-07	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—melanoma	8.09e-07	1.11e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—melanoma	8.02e-07	1.1e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—melanoma	6.86e-07	9.37e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3CA—melanoma	6.48e-07	8.85e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—melanoma	5.29e-07	7.23e-06	CbGpPWpGaD
